Jupiter Research Capital (Asia) Ltd’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Jupiter Research Capital (Asia) Ltd's NKTR Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 4,821 shares worth $292K. The stake represents 0.03% of the portfolio and ranks #497 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in NKTR as recently as Q1 2026.
Jupiter Research Capital (Asia) Ltd first reported a position in NKTR in Q1 2026 and has held it in 2 quarters since. The position peaked at $314K in Q1 2026. 235 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 4,821 shares of Nektar Therapeutics worth $292K as of Q3 2026.
- Nektar Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Nektar Therapeutics made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #497 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Nektar Therapeutics in Q1 2026 and has held it in 2 quarters since.
- Jupiter Research Capital (Asia) Ltd's Nektar Therapeutics position peaked at $314K in Q1 2026.
- 235 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.